Genetics update of macular diseases

Ophthalmology Clinics of North America

Volumn 15, Issue 4, 2002, Pages 459-465

  Chung, Mina ^a   Lotery, Andrew J ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; DRUSEN; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; GENOTYPE PHENOTYPE CORRELATION; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA VITELLIFORM DEGENERATION; RETINA MACULOPATHY; RETINA MALFORMATION; REVIEW; STARGARDT DISEASE;

EYE DISEASES, HEREDITARY; HUMANS; MOLECULAR BIOLOGY; RETINAL DISEASES;

EID: 0036951607     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-1549(02)00045-7     Document Type: Review

References (54)

1. Frangieh GT, Green WR, Fine SL. A histopathologic study of Best's macular dystrophy. Arch Ophthalmol 1982;100:1115-21.
2. Weingeist TA, Kobrin JL, Watzke RC. Histopathology of Best's macular dystrophy. Arch Ophthalmol 1982; 100:1108-14.
3. Forsman K, Graff C, Nordstrom S, et al. The gene for Best's macular dystrophy is located at 11q13 in a Swedish family. Clin Genet 1992;42:156-9.
4. Stone EM, Nichols BE, Streb LM, et al. Genetic linkage of vitelliform macular degeneration (Best's disease) to chromosome 11q13. Nat Genet 1992;1:246-50.
5. Marquardt A, Stohr H, Passmore LA, et al. Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best's disease). Hum Mol Genet 1998;7(9):1517-25.
6. Petrukhin K, Koisiti MJ, Bakall B, et al. Identification of the gene responsible for Best macular dystrophy. Nat Genet 1998;19:241-7.
7. Marmorstein AD, Marmorstein LY, Rayborn M, et al. Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium. Proc Natl Acad Sci U S A 2000;97:12758-63.
8. Lotery AJ, Munier FL, Fishman GA, et al. Allelic variation in the VMD2 gene in Best disease and age-related macular degeneration. Invest Ophthalmol Vis Sci 2000;41:1291-6.
9. th Edition. St Louis: CV Mosby; 1997.p. 303-435.
10. Kajiwara K, Sandberg MA, Berson EL, Dryja TP. A null mutation in the human peripherin/RDS gene in a family with autosomal dominant retinitis punctata albescens. Nat Genet 1993;3:208-12.
11. Nichols BE, Sheffield VC, Vandenburgh K, et al. Butterfly-shaped pigment dystrophy of the fovea caused by a point mutation in codon 167 of the RDS gene. Nat Genet 1993;3:202-7.
12. Wells J, Wroblewski J, Keen J, et al. Mutations in the human retinal degeneration slow (RDS) gene can cause either retinitis pigmentosa or macular dystrophy. Nat Genet 1993;3:213-8.
13. Farrar JG, Kenna P, Jordan SA, et al. A three-base-pair deletion in the peripherin-RDS gene in one form of retinitis pigmentosa. Nature 1991;354:478-80.
14. Kajiwara K, Hahn LB, Mukai S, et al. Mutation in the human retinal degeneration slow gene in autosomal dominant retinitis pigmentosa. Nature 1991;354: 478-80.
15. Connell GJ, Molday RS. Molecular cloning, primary structure, and orientation of the vertebrate photoreceptor cell protein peripherin in the rod outer segment disk membrane. Biochemistry 1990;29:4691-8.
16. Kaijiwara K, Berson EL, Dryja TP. Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROMI loci. Science 1994;264:1604-8.
17. Stone EM, Sheffield VC, Hageman GS. Molecular genetics of age-related macular degeneration. Hum Mol Genet 2001;10:2285-92.
18. Weleber RG, Carr RE, Murphey WH, et al. Phenotypic variation including retinitis pigmentosa, pattern dystrophy, and fundus flavimaculatus in a single family with a deletion of codon 153 and 154 of the peripherin/rds gene. Arch Ophthalmol 1993;111:1531-42.
19. Aaberg TM. Stargardt's disease and fundus flavimaculatus: Evaluation ofmorphologic progression and intrafamilial co-existence. Trans Am Ophthalmol Soc 1986;84:453-87.
20. Lois N, Holder GE, Fitzke FW, Plant C, Bird AC. Intrafamilial variation of phenotype in Stargardt macular dystrophy-fundus flavimaculatus. Invest Ophthalmol Vis Sci 1999;40:2668-75.
21. Fishman GA, Stone EM, Grover S, et al. Variation of clinical expression in patients with Stargardt dystrophy and sequence variations in the ABCR gene. Arch Ophthalmol 1999;117:504-10.
22. Lois N, Holder GE, Bunce C, et al. Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus. Arch Ophthalmol 2001;119:359-69.
23. Fishman GA, Farber M, Patel BS, et al. Visual acuity loss in patients with Stargardt's macular dystrophy. Ophthalmology 1987;94:809-14.
24. Kaplan J, Gerber S, Larget-Piet D, et al. A gene for Stargardt's disease (fundus flavimaculatus) maps to the short arm of chromosome 1. Nat Genet 1993;5: 308-11.
25. Allikmets R, Singh N, Sun H, et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet 1997;15:236-46.
26. Molday LL, Rabin AR, Molday RS. ABCR expression in foveal cone photoreceptors and its role in Stargardt macular dystrophy. Nat Genet 2000;25:257-8.
27. Sun H, Nathans J. Stargardt's ABCR is localized to the disc membrane of retinal rod outer segments. Nat Genet 1997;15:236-46.
28. Sun H, Molday RS, Nathans J. Retinal stimulates ATP hydrolysis by purified reconstituted ABCR, the photoreceptor-specific ATP-binding cassette transporter responsible for Stargardt disease. J Biol Chem 1999; 274:8269-81.
29. Weng J, Mata NL, Azarian SM, et al. Insights into the function of rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in ABCR knockout mice. Cell 1999;98:13-23.
30. Mata NL, Weng J, Travis GH. Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration. Proc Natl Acad Sci U S A 2000;97:7154-9.
31. Allikmets R, Shroyer NG, Singh N, et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 1997;277:1805-7.
32. De La Paz MA, Guy VK, Abou-Donia S, et al. Analysis of the Stargardt disease gene (ABCR) in age-related macular degeneration. Ophthalmology 1999; 106:1531-6.
33. Stone EM, Webster AR, Vandenburgh K, et al. Allelic variation in ABCR associated with Stargardt disease but not age-related macular degeneration. Nat Genet 1998;20:328-9.
34. Weeks DE, Conley YP, Mah TS, et al. A full genome scan for age-related maculopathy. Hum Mol Genet 2000;9:1329-49.
35. Guymer RH, Heon E, Lotery AJ, et al. Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration. Arch Ophthalmol 2001;119:745-51.
36. Webster AR, Heon E, Lotery AJ, et al. An analysis of allelic variation in the ABCA4 gene. Invest Ophthalmol Vis Sci 2001;42:1179-89.
37. Klein BA, Krill AE. Fundus flavimaculatus. Clinical, functional and histopathologic observations. Am J Ophthalmol 1967;64:3-23.
38. Cibis GW, Morey M, Harris DJ. Dominantly inherited macular dystrophy with flecks (Stargardt). Arch Ophthalmol 1980;98:1785-9.
39. Donoso LA, Edwards AO, Frost A, et al. Autosomal dominant Stargardt-like macular dystrophy. Survey 2001;46:149-63.
40. Stone EM, Nichols BE, Kimura AE, et al. Clinical features of a Stargardt-like dominant progressive macular dystrophy with genetic linkage to chromosome 6. Arch Ophthalmol 1994;112:765-72.
41. Donoso LA, Frost AT, Stone EM, et al. Autosomal dominant Stargardt-like macular dystrophy: Founder effect and reassessment of genetic heterogeneity. Arch Ophthalmol 2001;119:564-70.
42. Zhang K, Kniazeva M, Han M, et al. A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat Genet 2001; 27:89-93.
43. Cho E, Hung S, Willet WC, et al. Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr 2001;73:209-18.
44. Smith W, Mitchell P, Leeder SR. Dietary fat and fish intake and age-related maculopathy. Arch Ophthalmol 2000;118:401-4.
45. Heon E, Piguet B, Munier F, et al. Linkage of autosomal dominant radial drusen (malattia leventinese) to chromosome 2p16-21. Arch Ophthalmol 1996;114: 193-8.
46. Gregory CY, et al. The gene responsible for autosomal dominant Doyne's homeycomb retinal dystrophy (DHRD) maps to chromosome 2p16. Hum Mol Genet 1996;5:1055-9.
47. Stone EM, Lotery AJ, Munier FL, et al. A single EFEMP1 mutation is associated with both malattia leventinese and Doyne honeycomb retinal dystrophy. Nat Genet 1999;22:199-202.
48. Weber BH, Vogt G, Pruett RC, et al. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genet 1994;8:352-6.
49. Langton KP, Barker MD, McKie N. Localization of the functional domains of human tissue inhibitor of metalloproteinases - 3 and the effects of a Sorsby's fundus dystrophy mutation. J Biol Chem 1998;273: 16778-81.
50. Capon MR, Marshall J, Krafft JI, et al. Sorsby's fundus dystrophy: a light and electron microscopic study. Ophthalmology 1989;96:1769-77.
51. Chong NH, Alexander RA, Gin T, et al. TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy. Invest Ophthalmol Vis Sci 2000;41:898-902.
52. Jacobson SG, Cideciyan AV, Regunath G, et al. Night blindness in Sorsby's fundus dystrophy reversed by vitamin A. Nat Genet 1995;11:27-32.
53. Klein ML, Schultz DW, Edwards A, et al. Age-related macular degeneration: Clinical features in a large family and linkage to chromosome 1q. Arch Ophthalmol 1998;116:1082-8.
54. rd Edition. St Louis: CV Mosby; 2001. p. 340-61.